Combination Therapy With Dabrafenib and Trametinib for Langerhans Cell Histiocytosis‐Associated Neurodegenerative Disease

Authors

Institutions

Publication Details

Journal
Pediatric Blood & Cancer
Published
2025-12-22
DOI
https://doi.org/10.1002/1545-5017.70034
Primary Topic
Histiocytic Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Combination Therapy With Dabrafenib and Trametinib for Langerhans Cell Histiocytosis‐Associated Neurodegenerative Disease

Tomoyuki Utano, Ko Kudo, Yoshihiro Gocho, Itaru Hayakawa et al.
Pediatric Blood & Cancer
Histiocytic Disorders and Treatments
article

Combination Therapy With Dabrafenib and Trametinib for Langerhans Cell Histiocytosis‐Associated Neurodegenerative Disease

Tomoyuki Utano, Ko Kudo, Yoshihiro Gocho, Itaru Hayakawa, Shiho Yasue, Yoko Shioda, Nobuaki Tsuiki, Kenichi Sakamoto, Yoshiyuki Tsutsumi
article en

Abstract

No abstract available for this paper.
Pediatric Blood & CancerVol. 73(2)
Shinshu University (JP), Hirosaki University (JP), National Center For Child Health and Development (JP), National Rehabilitation Center for Persons with Disabilities (JP), Gifu University (JP)
Good health and well-being
Openalex Percentile: Top 34%
Histiocytic Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.